Fail-safe drug infusion therapy system

Patent metadata

Field	Value
Publication number	US-12097351-B2
Application number	US-202017010607-A
Country	US
Kind code	B2
Filing date	Sep 2, 2020
Priority date	Sep 20, 2013
Publication date	Sep 24, 2024
Grant date	Sep 24, 2024

Abstract

A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.

First claim

What is claimed is:

1. A fail-safe drug infusion system comprising:
a user interface controller comprising
a first processor;
a first memory coupled with said first processor;
a user interface display coupled with said first processor;

a pump motor controller comprising
a second processor;
a second memory coupled with said second processor;
a secondary display coupled with said second processor;
wherein said second processor is configured to control a pump motor to deliver a fluid;
a communication link coupled with the user interface controller and the pump motor controller;
wherein said first processor and said second processor are communicatively synchronized via said communication link;
wherein each of said first memory of said first processor and said second memory of said second processor comprise redundant drug infusion delivery information;
wherein said first processor is configured to send a first delivery request to said second processor;
wherein when said second processor receives said first delivery request from said first processor and command said pump motor to deliver said fluid; and
wherein if said first processor fails or if said communication link between said first processor and said second processor is interrupted, said second processor is configured to continue to apply fail-safe therapy to command said pump motor to deliver said fluid,
wherein the pump motor controller is in a same hardware architecture with the user interface controller.

2. The fail-safe drug infusion system of claim 1 , wherein when said pump motor delivers said fluid, said second processor is configured to create a status report with status report information, such that said second processor is configured to send said status report information to said first processor.

3. The fail-safe drug infusion system of claim 2 , wherein first processor is configured to receive said status report information from said second processor and update a fluid delivery status display on said user interface display, wherein said information comprises at least one of
activated fluid deliveries and,
completed fluid deliveries.

4. The fail-safe drug infusion system of claim 3 , wherein said first processor is configured to send a first delivery suspend request to said second processor in order to suspend said first delivery request.

5. The fail-safe drug infusion system of claim 4 , wherein said first processor is configured to send said first delivery suspend request when a user initiates a first delivery suspend command.

6. The fail-safe drug infusion system of claim 4 , wherein said second processor is configured to
receive said first delivery suspend request,
stop said pump motor delivery of said fluid prior to completion of said delivery of said fluid, such that undelivered fluid volume remains, and
suspend said first delivery request.

7. The fail-safe drug infusion system of claim 6 , wherein said first processor is configured to send a second delivery request to said second processor wherein when said second processor receives said second delivery request, said second processor is configured to command said pump motor to deliver fluid associated with said second delivery request.

8. The fail-safe drug infusion system of claim 7 , wherein when said second delivery request fluid delivery is completed, said second processor updates said fluid delivery status display, and said first processor is configured to send said suspended first delivery request to said second processor such that said pump motor delivers said remaining undelivered fluid volume.

9. The fail-safe drug infusion system of claim 7 , wherein if said communication link between said first processor and said second processor is interrupted during fluid delivery of said second delivery request, upon completion of said second delivery request, said second processor is configured to locate said suspended first delivery request and deliver said remaining undelivered fluid volume.

10. The fail-safe drug infusion system of claim 7 , wherein when said remaining undelivered fluid volume is delivered, said second processor is configured to process a next delivery request, such that said pump motor delivers said fluid.

11. The fail-safe drug infusion system of claim 6 , wherein when said remaining undelivered fluid volume is delivered, said first processor is configured to process a next delivery request, such that said pump motor delivers said fluid.

12. The fail-safe drug infusion system of claim 1 , wherein when said communication link between said first processor and said second processor is interrupted, said pump motor controller is configured to provide one or more of a visual alarm and an audio alarm on said secondary display.

13. The fail-safe drug infusion system of claim 1 , wherein the secondary display is a secondary user interface display and if said first processor fails or if said communication link between said first processor and said second processor is interrupted, said second processor is further configured to display a limited version of infusion information on said secondary user interface display that is normally displayed by said first processor.

14. The fail-safe drug infusion system of claim 1 , wherein said first processor or second processor or both include a drug library location parameter that enables the user interface controller or pump motor controller or both to operate in a desired manner associated with the location in which the user interface controller and pump motor controller are to operate.

Assignees

• Icu Medical Inc

Inventors

• Belkin Anatoly S
• Day William K
• Lindo Steve J
• Roman James P
• Stratan Andrei T

Classifications

• A61M2205/52

  with memories providing a history of measured variating parameters of apparatus or patient · CPC title

• A61M2205/502

  User interfaces, e.g. screens or keyboards · CPC title

• A61M2205/50

  with microprocessors or computers · CPC title

• A61M2205/35

  Communication · CPC title

• A61M2205/17

  with redundant control systems · CPC title